Sven Arne Andréasson
Director/Board Member bei MENDUS AB
Vermögen: - $ am 31.03.2024
Ursprung des Netzwerks ersten Grades von Sven Arne Andréasson
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Biotechnology | 39 | |
25
| Public Company | Biotechnology | 25 |
ERYTech Pharma SA
ERYTech Pharma SA Pharmaceuticals: MajorHealth Technology ERYTech Pharma SA is a biopharmaceutical company, which develops medical products. The firm conducts research and development of innovative red blood cell-based therapeutics for cancer and orphan diseases. The company was founded by Pierre-Olivier Goineau and Yann Godfrin on November 22, 2004 and is headquartered in Lyon, France.
24
| Extinct | Pharmaceuticals: Major | 24 |
Pharmacia AB
20
| Extinct | Pharmaceuticals: Major | 20 |
Holding Company | Medical Specialties | 9 | |
Public Company | Biotechnology | 8 | |
Cellastra, Inc.
Cellastra, Inc. BiotechnologyHealth Technology The American company was founded by Karl L. Mettinger and Kent Persson, with Karl L. Mettinger serving as CEO since incorporation.
5
| Private Company | Biotechnology | 5 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Sven Arne Andréasson
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
BAXTER INTERNATIONAL INC. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
ENZON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal Comptroller/Controller/Auditor Sales & Marketing Corporate Officer/Principal | |
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
ONCOLYTICS BIOTECH INC. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Executive Officer | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
MERSANA THERAPEUTICS, INC. | Biotechnology | Chairman Director/Board Member | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Chief Executive Officer | |
Omthera Pharmaceuticals, Inc.
Omthera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Omthera Pharmaceuticals, Inc. operates as pharmaceuticals company which focuses on the clinical development of new therapies for dyslipidemia. The company was founded by Jerry Wisler and Michael Davidson in 2008 and is headquartered in Princeton, NJ. | Pharmaceuticals: Major | Director/Board Member Chief Operating Officer | |
TESARO INC | Pharmaceuticals: Major | Founder Chairman Corporate Officer/Principal | |
Dartmouth College | College/University | Director/Board Member Undergraduate Degree Undergraduate Degree | |
BIOINVENT INTERNATIONAL AB | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer | |
MEDIVIR AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer Director of Finance/CFO | |
RECIPHARM AB (PUBL) | Biotechnology | Director/Board Member Founder Founder | |
Karolinska Institutet | College/University | Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal | |
NEA Management Co. LLC
NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
The Johns Hopkins University | College/University | Doctorate Degree Undergraduate Degree | |
Stockholm School of Economics | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree Graduate Degree | |
University of Uppsala | College/University | Graduate Degree Graduate Degree Undergraduate Degree Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Graduate Degree | |
IOMAI CORPORATION | Biotechnology | Chief Executive Officer Founder Chief Operating Officer | |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Compliance Officer | |
University of Lund | College/University | Doctorate Degree Graduate Degree Doctorate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree | |
University of Leiden | College/University | Doctorate Degree Doctorate Degree Graduate Degree | |
Katholieke Universiteit Leuven | College/University | Graduate Degree Graduate Degree Doctorate Degree Graduate Degree Doctorate Degree | |
American Society of Hematology
American Society of Hematology Miscellaneous Commercial ServicesCommercial Services American Society of Hematology provides the most current practice tools, clinical support and educational products needed in hematology. The firm offers educational products and services for clinicians and scientists. The company is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Université Catholique de Louvain | College/University | Graduate Degree Corporate Officer/Principal Graduate Degree | |
University of Lyon | College/University | Doctorate Degree Graduate Degree Graduate Degree Doctorate Degree | |
BIOARCTIC AB | Pharmaceuticals: Major | Chairman Corporate Officer/Principal Human Resources Officer | |
The United States Pharmacopeia
The United States Pharmacopeia Pharmaceuticals: MajorHealth Technology The United States Pharmacopeia engages in manufacturing medicines. It offers dietary supplements, and foods. The company is headquartered in Rockville, MD. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
InteRNA Technologies BV
InteRNA Technologies BV BiotechnologyHealth Technology InteRNA Technologies BV develops RNA technologies and applications. It provides drug discovery and development services for the treatment of cancer based on the proprietary microRNA (miRNA) functions. The company develops miRNA-based therapeutics that control genes connected in signal transduction pathways and biological processes as a part of cancer initiation, progression and metastasis. InteRNA Technologies was founded by Edwin Cuppen and Eugene Berezikov in December 2006 and is headquartered in Nijmegen, the Netherlands. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
Kabi Pharmacia | Corporate Officer/Principal Sales & Marketing | ||
FlandersBio vzw
FlandersBio vzw Miscellaneous Commercial ServicesCommercial Services FlandersBio vzw is a life sciences cluster organization based in Flanders, Belgium. FlandersBio creates value by organizing networking and training activities, supporting internationalization, providing services, and building expertise. The Belgian company was founded by Jean Marie Stassen. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal Director/Board Member | |
University of Nantes | College/University | Undergraduate Degree Doctorate Degree | |
DCPrime BV
DCPrime BV Pharmaceuticals: MajorHealth Technology DCPrime BV engages in the provision of therapeutic vaccines for the treatment of cancer. It develops whole-cell-based vaccine addressing blood cancers with a high risk of relapse. The company was founded by Ada M. Kruisbeek and Rik J. Scheper in March 2005 and is headquartered in Leiden, the Netherlands. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member Chief Executive Officer Chairman Director/Board Member | |
KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Director/Board Member Director/Board Member Chief Investment Officer | |
Columbia Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Vtesse, Inc.
Vtesse, Inc. BiotechnologyHealth Technology Vtesse, Inc. provides novel drugs for life-threatening rare diseases. It developed VTS-270, a modified form of cyclodextrin that has been evaluated in preclinical and clinical studies at institutes within the National Institutes of Health (NIH) to treat patients with Niemann-Pick Disease Type C (NPC). The firm is working with the NIH and other leading academic centers to advance clinical study of VTS-270 for NPC, and to conduct pre-clinical discovery and development of other novel drugs for NPC and other LSDs. The company was founded by Ben Machielse in 2015 and is headquartered in Gaithersburg, MD. | Biotechnology | Chairman Founder | |
Sigrid Therapeutics AB
Sigrid Therapeutics AB Medical SpecialtiesHealth Technology Sigrid Therapeutics AB engages in research and development in the area of weight loss and metabolic disorders. It focuses on therapies for prevention and treatment of lifestyle diseases. The company was founded by Sana Alajmovic and Tore Bengtsson in 2014 and is headquartered in Stockholm, Sweden. | Medical Specialties | Director/Board Member Director/Board Member | |
ENERGY HUNTER RESOURCES INC | Integrated Oil | Founder Director/Board Member | |
Synerkine Pharma BV
Synerkine Pharma BV Miscellaneous Commercial ServicesCommercial Services Synerkine Pharma BV focuses on developing novel fusion proteins for the treatment of inflammatory, neuropathic and osteoarthritic pain. The company was founded by Hans Preusting in 2018 and is headquartered in Utrecht, Netherlands. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member | |
Learning Undefeated, Inc.
Learning Undefeated, Inc. Investment Trusts/Mutual FundsMiscellaneous Learning Undefeated, Inc. is a non-profit organization that provides STEM education opportunities for underserved communities. The non-profit company is based in Gaithersburg. The American company's flagship education program features mobile STEM labs that have provided hands-on learning opportunities to more than 200,000 K-12 students in 18 states since 2003. The company also operates several other celebrated STEM education programs including the Young Science Explorers program, a summer camp for middle school students, and the Advancing Tomorrow's Leaders in STEM (ATLAS) college and career exploration program. Learning Undefeated is driving race and gender equity in STEM through experiential and deep-impact learning experiences for students from under-resourced communities. | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member Chairman | |
PHAXIAM THERAPEUTICS S.A. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director of Finance/CFO Director/Board Member Director/Board Member Chairman | |
Actinova AB | Director/Board Member Director/Board Member |
Statistik
International
Vereinigte Staaten | 25 |
Schweden | 13 |
Niederlande | 6 |
Belgien | 4 |
Frankreich | 4 |
Sektoral
Health Technology | 28 |
Consumer Services | 13 |
Commercial Services | 6 |
Finance | 3 |
Energy Minerals | 2 |
Operativ
Director/Board Member | 543 |
Corporate Officer/Principal | 250 |
Chairman | 195 |
Independent Dir/Board Member | 148 |
Chief Executive Officer | 115 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Peter James Arthur Benson | 58 |
Gunnar Magnus Modee Persson | 51 |
Rolf Classon | 47 |
David Mott | 45 |
Göran Albert Ando | 44 |
Thomas Bengt Eldered | 41 |
Wenche Nelly A. Rolfsen Sandsborg | 36 |
Peter Sjöstrand | 35 |
Rajiv Indravadan Modi | 31 |
Gail Boudreaux | 30 |
Claes Tomas Post | 30 |
Luc Dochez | 26 |
Marc Beer | 25 |
Dharminder Singh Chahal | 25 |
Gary Evans | 25 |
- Börse
- Insiders
- Sven Arne Andréasson
- Unternehmensverbindungen